| Primary |
| Blood Triglycerides Increased |
33.4% |
| Product Used For Unknown Indication |
21.0% |
| Drug Use For Unknown Indication |
19.7% |
| Blood Cholesterol Increased |
13.4% |
| Blood Cholesterol |
2.3% |
| Prophylaxis |
1.3% |
| Hypertension |
1.1% |
| Hyperlipidaemia |
1.0% |
| High Density Lipoprotein Decreased |
0.9% |
| Blood Triglycerides |
0.8% |
| Hypertriglyceridaemia |
0.8% |
| Low Density Lipoprotein Increased |
0.7% |
| Cardiac Disorder |
0.7% |
| Arthritis |
0.6% |
| Blood Cholesterol Decreased |
0.4% |
| Blood Pressure |
0.4% |
| Diabetes Mellitus |
0.4% |
| High Density Lipoprotein Increased |
0.4% |
| Arthralgia |
0.4% |
| Blood Cholesterol Abnormal |
0.4% |
|
| Product Quality Issue |
12.2% |
| Drug Ineffective |
8.3% |
| Therapeutic Response Unexpected |
6.8% |
| Nausea |
6.5% |
| Blood Triglycerides Increased |
6.2% |
| Eructation |
5.9% |
| Dysgeusia |
5.4% |
| Low Density Lipoprotein Increased |
5.1% |
| Diarrhoea |
4.9% |
| Vomiting |
4.4% |
| Rash |
4.3% |
| Gout |
4.0% |
| Hepatic Enzyme Increased |
3.9% |
| Skin Odour Abnormal |
3.7% |
| Abdominal Discomfort |
3.2% |
| Myalgia |
3.2% |
| Urticaria |
3.2% |
| Drug Administration Error |
3.1% |
| Dyspepsia |
2.9% |
| Constipation |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
28.4% |
| Blood Cholesterol Increased |
13.5% |
| Drug Use For Unknown Indication |
10.6% |
| Blood Triglycerides Increased |
10.3% |
| Blood Oestrogen Decreased |
5.3% |
| Hypertension |
3.6% |
| Anticoagulant Therapy |
2.9% |
| High Density Lipoprotein Decreased |
2.9% |
| Diabetes Mellitus |
2.6% |
| Fibromyalgia |
2.4% |
| Low Density Lipoprotein Increased |
2.4% |
| Menopause |
2.4% |
| Atrial Fibrillation |
2.2% |
| Blood Cholesterol Abnormal |
1.7% |
| Pain |
1.7% |
| Supplementation Therapy |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Osteoarthritis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Depression |
1.2% |
|
| Death |
13.9% |
| Pain In Extremity |
6.9% |
| Pruritus |
6.9% |
| Weight Increased |
6.9% |
| Drug Hypersensitivity |
5.6% |
| Gait Disturbance |
5.6% |
| Off Label Use |
5.6% |
| Syncope |
5.6% |
| Alopecia |
4.2% |
| Circumstance Or Information Capable Of Leading To Medication Error |
4.2% |
| Completed Suicide |
4.2% |
| Hepatic Enzyme Increased |
4.2% |
| High Density Lipoprotein Decreased |
4.2% |
| Liver Function Test Abnormal |
4.2% |
| Low Density Lipoprotein Increased |
4.2% |
| Activities Of Daily Living Impaired |
2.8% |
| Blood Amylase Increased |
2.8% |
| Blood Glucose Decreased |
2.8% |
| Blood Triglycerides Increased |
2.8% |
| Depression |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.2% |
| Drug Use For Unknown Indication |
16.2% |
| Hypertension |
6.0% |
| Blood Cholesterol Increased |
4.6% |
| Diabetes Mellitus |
2.5% |
| Pain |
2.4% |
| Blood Triglycerides Increased |
2.3% |
| Supplementation Therapy |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Osteoporosis |
1.9% |
| Vitamin Supplementation |
1.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Depression |
1.8% |
| Type 2 Diabetes Mellitus |
1.7% |
| Prophylaxis |
1.6% |
| High Density Lipoprotein Decreased |
1.5% |
| Cardiac Disorder |
1.5% |
| Atrial Fibrillation |
1.4% |
| Blood Cholesterol |
1.4% |
| Asthma |
1.3% |
|
| Flushing |
19.5% |
| Pruritus |
10.7% |
| Weight Increased |
5.8% |
| Paraesthesia |
5.5% |
| Weight Decreased |
5.5% |
| Vomiting |
5.2% |
| Headache |
4.6% |
| Drug Ineffective |
4.6% |
| Pain |
4.6% |
| Pain In Extremity |
4.0% |
| Skin Burning Sensation |
3.8% |
| Fatigue |
3.3% |
| Nausea |
3.2% |
| Rash |
3.2% |
| Feeling Hot |
3.1% |
| Blood Glucose Increased |
3.0% |
| Myalgia |
2.7% |
| Death |
2.7% |
| Dizziness |
2.7% |
| Urticaria |
2.4% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
20.0% |
| Drug Use For Unknown Indication |
16.7% |
| Product Used For Unknown Indication |
13.3% |
| Blood Triglycerides Increased |
10.0% |
| Diabetes Mellitus |
10.0% |
| Arthralgia |
3.3% |
| Blood Cholesterol |
3.3% |
| Blood Pressure |
3.3% |
| Blood Triglycerides |
3.3% |
| Colitis |
3.3% |
| Pain |
3.3% |
| Prostatic Disorder |
3.3% |
| Reflux Gastritis |
3.3% |
| Rotator Cuff Syndrome |
3.3% |
|
| Headache |
33.3% |
| Drug Interaction |
11.1% |
| Dry Eye |
11.1% |
| Eye Pruritus |
11.1% |
| Gastrooesophageal Reflux Disease |
11.1% |
| Paranoia |
11.1% |
| Pleural Effusion |
11.1% |
|
